144 related articles for article (PubMed ID: 34771699)
1. Proteomics as a Complementary Technique to Characterize Bladder Cancer.
López-Cortés R; Vázquez-Estévez S; Fernández JÁ; Núñez C
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771699
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for precision medicine in bladder cancer.
Kojima T; Kawai K; Miyazaki J; Nishiyama H
Int J Clin Oncol; 2017 Apr; 22(2):207-213. PubMed ID: 27896485
[TBL] [Abstract][Full Text] [Related]
3. Hope and challenge: Precision medicine in bladder cancer.
Su H; Jiang H; Tao T; Kang X; Zhang X; Kang D; Li S; Li C; Wang H; Yang Z; Zhang J; Li C
Cancer Med; 2019 Apr; 8(4):1806-1816. PubMed ID: 30907072
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture.
Elbadawy M; Usui T; Mori T; Tsunedomi R; Hazama S; Nabeta R; Uchide T; Fukushima R; Yoshida T; Shibutani M; Tanaka T; Masuda S; Okada R; Ichikawa R; Omatsu T; Mizutani T; Katayama Y; Noguchi S; Iwai S; Nakagawa T; Shinohara Y; Kaneda M; Yamawaki H; Sasaki K
Cancer Sci; 2019 Sep; 110(9):2806-2821. PubMed ID: 31254429
[TBL] [Abstract][Full Text] [Related]
5. microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes.
Pardini B; Cordero F; Naccarati A; Viberti C; Birolo G; Oderda M; Di Gaetano C; Arigoni M; Martina F; Calogero RA; Sacerdote C; Gontero P; Vineis P; Matullo G
Oncotarget; 2018 Apr; 9(29):20658-20669. PubMed ID: 29755679
[TBL] [Abstract][Full Text] [Related]
6. Prediction of muscle-invasive bladder cancer using urinary proteomics.
Schiffer E; Vlahou A; Petrolekas A; Stravodimos K; Tauber R; Geschwend JE; Neuhaus J; Stolzenburg JU; Conaway MR; Mischak H; Theodorescu D
Clin Cancer Res; 2009 Aug; 15(15):4935-43. PubMed ID: 19602546
[TBL] [Abstract][Full Text] [Related]
7. Proteomic research and diagnosis in bladder cancer: state of the art review.
Wilson JL; Antoniassi MP; Lopes PI; Azevedo H
Int Braz J Urol; 2021; 47(3):503-514. PubMed ID: 32459456
[TBL] [Abstract][Full Text] [Related]
8. Variant histology in bladder cancer: how it should change the management in non-muscle invasive and muscle invasive disease?
Klaile Y; Schlack K; Boegemann M; Steinestel J; Schrader AJ; Krabbe LM
Transl Androl Urol; 2016 Oct; 5(5):692-701. PubMed ID: 27785426
[TBL] [Abstract][Full Text] [Related]
9. Molecular Subtype Profiling of Urothelial Carcinoma Using a Subtype-Specific Immunohistochemistry Panel.
Sjödahl G
Methods Mol Biol; 2018; 1655():53-64. PubMed ID: 28889377
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?
Gazquez C; Ribal MJ; Marín-Aguilera M; Kayed H; Fernández PL; Mengual L; Alcaraz A
BJU Int; 2012 Nov; 110(9):1310-6. PubMed ID: 22416928
[TBL] [Abstract][Full Text] [Related]
11. Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer.
Chedgy EC; Douglas J; Wright JL; Seiler R; van Rhijn BW; Boormans J; Todenhöfer T; Dinney CP; Collins CC; Van der Heijden MS; Black PC
Urol Oncol; 2016 Oct; 34(10):469-76. PubMed ID: 27317490
[TBL] [Abstract][Full Text] [Related]
12. Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.
Latosinska A; Frantzi M; Vlahou A; Merseburger AS; Mischak H
Proteomics Clin Appl; 2018 Mar; 12(2):. PubMed ID: 28980455
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.
van Rhijn BW; Liu L; Vis AN; Bostrom PJ; Zuiverloon TC; Fleshner NE; van der Aa MN; Alkhateeb SS; Bangma CH; Jewett MA; Zwarthoff EC; Bapat B; van der Kwast TH; Zlotta AR
BJU Int; 2012 Oct; 110(8):1169-76. PubMed ID: 22448597
[TBL] [Abstract][Full Text] [Related]
14. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
[TBL] [Abstract][Full Text] [Related]
15. Profilin 1 is a potential biomarker for bladder cancer aggressiveness.
Zoidakis J; Makridakis M; Zerefos PG; Bitsika V; Esteban S; Frantzi M; Stravodimos K; Anagnou NP; Roubelakis MG; Sanchez-Carbayo M; Vlahou A
Mol Cell Proteomics; 2012 Apr; 11(4):M111.009449. PubMed ID: 22159600
[TBL] [Abstract][Full Text] [Related]
16. Proteome-based classification of Nonmuscle Invasive Bladder Cancer.
Stroggilos R; Mokou M; Latosinska A; Makridakis M; Lygirou V; Mavrogeorgis E; Drekolias D; Frantzi M; Mullen W; Fragkoulis C; Stasinopoulos K; Papadopoulos G; Stathouros G; Lazaris AC; Makrythanasis P; Ntoumas K; Mischak H; Zoidakis J; Vlahou A
Int J Cancer; 2020 Jan; 146(1):281-294. PubMed ID: 31286493
[TBL] [Abstract][Full Text] [Related]
17. SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor.
Chiang CY; Pan CC; Chang HY; Lai MD; Tzai TS; Tsai YS; Ling P; Liu HS; Lee BF; Cheng HL; Ho CL; Chen SH; Chow NH
Clin Cancer Res; 2015 Dec; 21(24):5601-11. PubMed ID: 26286913
[TBL] [Abstract][Full Text] [Related]
18. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions.
Ng K; Stenzl A; Sharma A; Vasdev N
Urol Oncol; 2021 Jan; 39(1):41-51. PubMed ID: 32919875
[TBL] [Abstract][Full Text] [Related]
19. Precision medicine in localized bladder cancer: Personalizing therapies to improve outcomes.
Carando R; Ludovico GM; Zazzara M; Zamboni S; Afferi L; Simeone C; Krajewski W; Moschini M
Arch Esp Urol; 2020 Dec; 73(10):1016-1022. PubMed ID: 33269720
[TBL] [Abstract][Full Text] [Related]
20. Immune Checkpoint Inhibitors in Urothelial Bladder Cancer: State of the Art and Future Perspectives.
Roviello G; Catalano M; Santi R; Palmieri VE; Vannini G; Galli IC; Buttitta E; Villari D; Rossi V; Nesi G
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
